Human iPSC-Derived Skeletal Muscle Myoblasts
- Specification
- Background
- Scientific Data
- Q & A
- Customer Review
Human iPSC-derived skeletal muscle myoblasts arise from human induced pluripotent stem cells that have been guided through key developmental stages of muscle formation. These cells share many properties of primary myoblasts such as expression of myogenic regulatory factors (e.g., MYOD, MYOG) and are capable of fusing to form multinucleated myotubes.
Human iPSC-derived skeletal muscle myoblasts have been used as a robust system to study human muscle development and disease. Through precise differentiation protocols and tissue engineering techniques, they can be used to generate contractile 2D and 3D muscle tissues for studies of myogenesis and muscle repair. Culture of muscle cells with motor neurons or endothelial cells allows for increased myofiber maturation and contractile function by more closely resembling the in vivo muscle microenvironment.
Human iPSC-derived skeletal muscle myoblasts have been broadly used for disease modeling applications, most commonly for neuromuscular diseases like Duchenne muscular dystrophy. Using iPSCs derived from patients with disease, researchers can create patient-specific models of disease on a cell-autonomous level and test therapies. More recently, iPSC-derived skeletal muscle myoblasts have also been employed for drug screening applications. Micro-engineered 96-well contractile muscle screens have been developed for high-throughput assays of drug toxicity and pharmacology.
ERBB3+/NGFR+ Population of Human iPSC-Derived Myoblasts Exhibits Rapid Differentiation to Myotubes
Neurovascular cells play important roles in skeletal muscle biology, including myogenesis, maturation, and regeneration. While in vitro studies have examined motor neurons and endothelial cells independently, their combined effects on muscle development remain unclear. Here, Das et al. developed a triculture system using human iPSC-derived skeletal myocytes, iPSC-derived motor neurons, and primary human endothelial cells, maintained under controlled media conditions.
The human iPSC line Penn123i-SV20 was differentiated into a mixture of myocytes, myotubes, and skeletal muscle progenitor cells (SMPCs) as described. Cells were enriched using antibodies against ERBB3 and NGFR, markers of PAX7+ myogenic progenitors, then expanded and cryopreserved as SMPCs for later myotube formation. ERBB3+NGFR+ cells efficiently formed myotubes within 4 days after initiating differentiation (Fig. 1).
Quantitative PCR showed increased expression of myogenic transcription factors (PAX7, MYOD1, MYOG), structural proteins (DMD, TNNT1, TTN), and myosin heavy chain genes (MYH1, MYH3, MYH6, MYH7, MYH8) (Fig. 1B), consistent with prior reports. Myogenic identity was confirmed by uniform expression of skeletal myosin heavy chain (MYHC) and embryonic MYH3 (Fig. 1C). Based on these findings, ERBB3+/NGFR+ myoblasts were used as the starting cell source for all subsequent experiments.

Ask a Question
Write your own review
- Adipose Tissue-Derived Stem Cells
- Human Neurons
- Mouse Probe
- Whole Chromosome Painting Probes
- Hepatic Cells
- Renal Cells
- In Vitro ADME Kits
- Tissue Microarray
- Tissue Blocks
- Tissue Sections
- FFPE Cell Pellet
- Probe
- Centromere Probes
- Telomere Probes
- Satellite Enumeration Probes
- Subtelomere Specific Probes
- Bacterial Probes
- ISH/FISH Probes
- Exosome Isolation Kit
- Human Adult Stem Cells
- Mouse Stem Cells
- iPSCs
- Mouse Embryonic Stem Cells
- iPSC Differentiation Kits
- Mesenchymal Stem Cells
- Immortalized Human Cells
- Immortalized Murine Cells
- Cell Immortalization Kit
- Adipose Cells
- Cardiac Cells
- Dermal Cells
- Epidermal Cells
- Peripheral Blood Mononuclear Cells
- Umbilical Cord Cells
- Monkey Primary Cells
- Mouse Primary Cells
- Breast Tumor Cells
- Colorectal Tumor Cells
- Esophageal Tumor Cells
- Lung Tumor Cells
- Leukemia/Lymphoma/Myeloma Cells
- Ovarian Tumor Cells
- Pancreatic Tumor Cells
- Mouse Tumor Cells